FRINK Linked Data Fragments server

Matches in Wikidata for { <http://www.wikidata.org/entity/Q50707322> ?p ?o ?g. }

• Q50707322 description "2017 nî lūn-bûn" @default.
• Q50707322 description "2017年の論文" @default.
• Q50707322 description "2017年学术文章" @default.
• Q50707322 description "2017年学术文章" @default.
• Q50707322 description "2017年学术文章" @default.
• Q50707322 description "2017年学术文章" @default.
• Q50707322 description "2017年学术文章" @default.
• Q50707322 description "2017年学术文章" @default.
• Q50707322 description "2017年學術文章" @default.
• Q50707322 description "2017年學術文章" @default.
• Q50707322 description "2017年學術文章" @default.
• Q50707322 description "2017年學術文章" @default.
• Q50707322 description "2017年學術文章" @default.
• Q50707322 description "2017년 논문" @default.
• Q50707322 description "article científic" @default.
• Q50707322 description "article scientific" @default.
• Q50707322 description "article scientifique" @default.
• Q50707322 description "articol științific" @default.
• Q50707322 description "articolo scientifico" @default.
• Q50707322 description "artigo científico" @default.
• Q50707322 description "artigo científico" @default.
• Q50707322 description "artigo científico" @default.
• Q50707322 description "artikel ilmiah" @default.
• Q50707322 description "artikull shkencor" @default.
• Q50707322 description "artikulong pang-agham" @default.
• Q50707322 description "artykuł naukowy" @default.
• Q50707322 description "artículo científico publicado en 2017" @default.
• Q50707322 description "artículu científicu" @default.
• Q50707322 description "bilimsel makale" @default.
• Q50707322 description "bài báo khoa học" @default.
• Q50707322 description "naučni članak" @default.
• Q50707322 description "scienca artikolo" @default.
• Q50707322 description "scientific article published on 18 April 2017" @default.
• Q50707322 description "scientific article published on 18 April 2017" @default.
• Q50707322 description "scientific article published on 18 April 2017" @default.
• Q50707322 description "teaduslik artikkel" @default.
• Q50707322 description "tieteellinen artikkeli" @default.
• Q50707322 description "tudományos cikk" @default.
• Q50707322 description "vedecký článok" @default.
• Q50707322 description "vetenskaplig artikel" @default.
• Q50707322 description "videnskabelig artikel" @default.
• Q50707322 description "vitenskapelig artikkel" @default.
• Q50707322 description "vitskapeleg artikkel" @default.
• Q50707322 description "vědecký článek" @default.
• Q50707322 description "wetenschappelijk artikel" @default.
• Q50707322 description "wissenschaftlicher Artikel" @default.
• Q50707322 description "επιστημονικό άρθρο" @default.
• Q50707322 description "мақолаи илмӣ" @default.
• Q50707322 description "наукова стаття, опублікована у квітні 2017" @default.
• Q50707322 description "научна статия" @default.
• Q50707322 description "научная статья" @default.
• Q50707322 description "научни чланак" @default.
• Q50707322 description "научни чланак" @default.
• Q50707322 description "գիտական հոդված հրատարակված 2017 թվականի ապրիլի 18-ին" @default.
• Q50707322 description "מאמר מדעי" @default.
• Q50707322 description "مقالة علمية نشرت في 18 أبريل 2017" @default.
• Q50707322 description "১৮ এপ্রিল ২০১৭-এ প্রকাশিত বৈজ্ঞানিক নিবন্ধ" @default.
• Q50707322 description "บทความทางวิทยาศาสตร์" @default.
• Q50707322 description "სამეცნიერო სტატია" @default.
• Q50707322 name "Assessing the Eligibility Criteria in Phase III Randomized Controlled Trials of Drug Therapy in Heart Failure With Preserved Ejection Fraction: The Critical Play-Off Between a "Pure" Patient Phenotype and the Generalizability of Trial Findings." @default.
• Q50707322 name "Assessing the Eligibility Criteria in Phase III Randomized Controlled Trials of Drug Therapy in Heart Failure With Preserved Ejection Fraction: The Critical Play-Off Between a "Pure" Patient Phenotype and the Generalizability of Trial Findings." @default.
• Q50707322 type Item @default.
• Q50707322 label "Assessing the Eligibility Criteria in Phase III Randomized Controlled Trials of Drug Therapy in Heart Failure With Preserved Ejection Fraction: The Critical Play-Off Between a "Pure" Patient Phenotype and the Generalizability of Trial Findings." @default.
• Q50707322 label "Assessing the Eligibility Criteria in Phase III Randomized Controlled Trials of Drug Therapy in Heart Failure With Preserved Ejection Fraction: The Critical Play-Off Between a "Pure" Patient Phenotype and the Generalizability of Trial Findings." @default.
• Q50707322 prefLabel "Assessing the Eligibility Criteria in Phase III Randomized Controlled Trials of Drug Therapy in Heart Failure With Preserved Ejection Fraction: The Critical Play-Off Between a "Pure" Patient Phenotype and the Generalizability of Trial Findings." @default.
• Q50707322 prefLabel "Assessing the Eligibility Criteria in Phase III Randomized Controlled Trials of Drug Therapy in Heart Failure With Preserved Ejection Fraction: The Critical Play-Off Between a "Pure" Patient Phenotype and the Generalizability of Trial Findings." @default.
• Q50707322 P1433 Q50707322-288BA763-9453-4A46-B251-845BE6C4F32A @default.
• Q50707322 P1476 Q50707322-56AF58C1-5D7C-4E2E-AA54-A74D50F1AF09 @default.
• Q50707322 P2093 Q50707322-1E5E7F68-2F80-46AE-9D48-37739AE42EE8 @default.
• Q50707322 P2093 Q50707322-22D70D7A-0FF7-416E-9CFA-07A02FE27A72 @default.
• Q50707322 P2093 Q50707322-39667CE8-2336-4C23-BC03-71A1D4327878 @default.
• Q50707322 P2093 Q50707322-530F18C3-49C5-4F7F-B698-2AC843DE38A5 @default.
• Q50707322 P2093 Q50707322-89E7DCE1-03B6-43C0-8669-B35A8DECDD30 @default.
• Q50707322 P2093 Q50707322-9F449394-3D38-4CAD-A351-D0064BC7EBCE @default.
• Q50707322 P2093 Q50707322-DAEEF0B2-3302-45A5-B74C-E194AA3111C2 @default.
• Q50707322 P2093 Q50707322-E6499113-4794-4A93-B75B-5621D918870B @default.
• Q50707322 P304 Q50707322-A2E36BBF-D4E1-4A0F-89BB-F49A420A9FF9 @default.
• Q50707322 P31 Q50707322-2FC01CED-A8DD-4413-BF1A-D3E7C26D7F18 @default.
• Q50707322 P356 Q50707322-04FA80AC-BDEB-4C45-8BC4-90E0A1769D12 @default.
• Q50707322 P433 Q50707322-FBBEBFE7-C044-4E46-A49B-A83E4D48B8D8 @default.
• Q50707322 P478 Q50707322-3024B62F-83C0-4013-8B38-410BAB1FCF4A @default.
• Q50707322 P50 Q50707322-87216CD7-C1C1-4002-897D-0F944C99CF74 @default.
• Q50707322 P50 Q50707322-B8B574B7-CD67-4884-845E-30DCF28D68EA @default.
• Q50707322 P577 Q50707322-C0907D78-F31A-45BD-8A37-D2CA73F05288 @default.
• Q50707322 P698 Q50707322-EE3CFD89-C473-46EC-9434-FFA437D3DDF5 @default.
• Q50707322 P921 Q50707322-84C70817-5758-4661-8358-C16357B24D9D @default.
• Q50707322 P921 Q50707322-B1CF0BF5-4834-4079-974E-361F6A631260 @default.
• Q50707322 P921 Q50707322-B7B79C08-9D6F-4F69-82CA-CA70300D6B81 @default.
• Q50707322 P921 Q50707322-E7AE5C1F-308B-4A5D-8F2C-2C944487B46F @default.
• Q50707322 P921 Q50707322-EC5E1790-35B1-4821-871E-86BA44F3A737 @default.
• Q50707322 P356 J.CARDFAIL.2017.04.006 @default.
• Q50707322 P698 28434933 @default.
• Q50707322 P1433 Q2134415 @default.
• Q50707322 P1476 "Assessing the Eligibility Criteria in Phase III Randomized Controlled Trials of Drug Therapy in Heart Failure With Preserved Ejection Fraction: The Critical Play-Off Between a "Pure" Patient Phenotype and the Generalizability of Trial Findings" @default.
• Q50707322 P2093 "Abdel Saidmeerasah" @default.
• Q50707322 P2093 "Carl Hayward" @default.
• Q50707322 P2093 "Hitesh C Patel" @default.
• Q50707322 P2093 "Lisa J Anderson" @default.
• Q50707322 P2093 "Martin R Cowie" @default.
• Q50707322 P2093 "Nesan Shanmugam" @default.

• next